 "Zydus Cadila get USFDA nod for Clonidine Hcl injections")
The approval from the US Food and Drug Administration (USFDA) is for Clonidine Hcl injections of strength 0.1mg/ml, 0.5mg/ml and 10mg/ml the company said in a filing to the BSE.
The injection is used in treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone.
Also Read
The company has now 90 approvals and has so far filed 216 abbreviated new drug applications since the filing process began in 2003-04, it added.
Shares of the company closed 4.69 per cent higher at Rs 995.10 apiece on the BSE today.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%